Swedish Orphan Biovitrum AB (publ): Bo Jesper Hansen sells 8 million shares
(Thomson Reuters ONE) -
Bo Jesper Hansen sells 8 million shares
Bo Jesper Hansen has sold 8,000,000 of the shares he holds in Swedish Orphan
Biovitrum AB (publ) (Sobi(TM)). He now owns 893,846 shares in Sobi.
On 26 February 2016 Sobi announced that Chairman Bo Jesper Hansen had informed
Sobi's nomination committee that he will not stand for re-election at the 2016
Annual General Meeting of shareholders which will be held 24 May 2016. Håkan
Björklund, former Nycomed CEO and Lundbeck Chairman, has been nominated as the
new Chairman of the Board.
---
About Sobi(TM)
Sobi(TM) is an international specialty healthcare company dedicated to rare
diseases. Our mission is to develop and deliver innovative therapies and
services to improve the lives of patients. The product portfolio is primarily
focused on Haemophilia, Inflammation and Genetic diseases. We also market a
portfolio of specialty and rare disease products for partner companies across
Europe, the Middle East, North Africa and Russia. Sobi is a pioneer in
biotechnology with world-class capabilities in protein biochemistry and
biologics manufacturing. In 2015, Sobi had total revenues of SEK 3.2 billion
(USD 380 M) and about 700 employees. The share (STO: SOBI) is listed on NASDAQ
OMX Stockholm. More information is available at www.sobi.com.
For more information please contact
Media relations Investor relations
Oskar Bosson, Head of Jörgen Winroth, Vice President, Head of Investor
Communications Relations
+46 70 410 71 80 +1 347-224-0819, +1 212-579-0506, +46 8 697 2135
oskar.bosson(at)sobi.com jorgen.winroth(at)sobi.com
The information set out in this press release is announced in accordance with
the Swedish Securities Market Act. The information was submitted for publication
on 4 May 2016 at 08:00 CET.
024e_BJH sells shares:
http://hugin.info/134557/R/2009660/743729.pdf
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Swedish Orphan Biovitrum AB (publ) via GlobeNewswire
[HUG#2009660]
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
" alt="Cypress Adds Additional Lithium Claims to its Clayton Valley Lithium Project in NevadaDatum: 04.05.2016 - 08:00 Uhr
Sprache: Deutsch
News-ID 468545
Anzahl Zeichen: 2807
contact information:
Town:
Stockholm
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 188 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Swedish Orphan Biovitrum AB (publ): Bo Jesper Hansen sells 8 million shares"
steht unter der journalistisch-redaktionellen Verantwortung von
Swedish Orphan Biovitrum AB (publ) (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
